Assertio reports third quarter 2024 financial results

Third quarter total net product sales of $28.7 million rolvedon net product sales of $15.0 million  cash and short-term investments of $88.6 million lake forest, ill., nov. 11, 2024 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today reported financial results for the third quarter ended september 30, 2024.
ASRT Ratings Summary
ASRT Quant Ranking